Rotate Your Device

This site doesn't support landscape mode. Please rotate your phone to portrait.

Kenvue

Kenvue

Kenvue is the world’s largest pure-play consumer health company by revenue. Built on more than a century of heritage and propelled forward by science, our iconic brands — including Aveeno®, BAND-AID® Brand Adhesive Bandages, Johnson’s®, Listerine®, Neutrogena®, Tylenol® and Zyrtec® — are recommended by health care professionals and can be trusted by consumers who use our products to improve their daily lives. Our team members share a digital-first mindset, with an approach to innovation grounded in deep human insights and work every day to earn a place for our products in consumers’ hearts and homes. At Kenvue, we believe everyday care can not only make people well; it can make them whole. Beware of recruitment scams: https://www.kenvue.com/media/recruitment-scams-alert

Summit, New Jersey, United States10001-undefined employeesFounded 2023

Overview

Kenvue is a consumer health company that delivers personal health solutions. The company's brands operate through three primary business segments: Self Care (over-the-counter medications and wellness products), Skin Health & Beauty (skincare and personal-care brands), and Essential Health (hygiene, baby care, and other foundational health products). The company emphasizes innovation and science-backed care, stating that it leverages more than 135 years of heritage and invests in R&D to develop new products and solutions.

Tech Stack

DnssecU.s. server locationGoogle font apiMobile non scaleable contentFont awesomeCloudflare jsCdn jsCloudflare network error loggingFacebook sharerApple mobile web app capableAppNexusBootstrap FrameworkBrontoCloudFlare CDNCloudFlare HostingDoubleClickDoubleClick ConversionDoubleClick FloodlightDrupalGoogle AnalyticsGoogle Dynamic RemarketingGoogle Font APIGoogle Tag ManagerIntercomJanrainLinkedin Marketing SolutionsMicrosoft Office 365Mobile FriendlyNSOneNew RelicRocketFuelShopifyTaleoVarnishYahoo Ad Manager PlusYahoo AnalyticsYotpoYouTubeReCAPTCHA

Funding History

Post Ipo Secondary

$3.6B

May 2024

Goldman Sachs, J.P. Morgan Securities Inc.

Post Ipo Equity

Undisclosed

Oct 2024

Starboard Value

Post Ipo Equity

Undisclosed

Apr 2025

Third Point